For the 19th time, ABL’s ABBY Awards will recognize and celebrate organizations that have developed and brought to market innovative approaches, med devices, health information – and digital health technologies, that are reducing the cost of quality healthcare. And this year, more than any other before, many of these innovations are blending technology with the human touch provided by providers, caregivers, and even family members and friends!

Come vote for the Innovations in Healthcare you think are most dramatically reducing the cost of quality care!

Keynote Presenter

Robert Maloney, MD

Director, Maloney Vision Institute
Clinical Professor of Ophthalmology, David Geffen School of Medicine at UCLA

Our Keynoter, Dr. Robert Maloney, is an innovator himself, having worked at the forefront of innovative vision correction surgery for 20 years – personally performing over 60,000 vision correction procedures – including on Kim Kardashian. He’s also a brilliant medical edu-tainer, as he’ll share with us the inspiring backstory of one of the greatest Innovations in Healthcare of all time, and how it’s played out in history and art – as well as today’s routine medical practice. It’s a presentation you’ll never forget.

WHICH FINALIST WILL YOU VOTE FOR
TO WIN THE 2018 ABBY AWARD?

Advanced Pathways

Traci Patterson, Founder & Executive Director

Advanced Pathways’ Hypnosis Combined Therapy (HCT) provides solutions for chronic pain patients (CRPS, Fibromyalgia, SFN, Migraines, etc.) through a personalized, evidence based, non-invasive, drug free treatment option that allows patients to regain their lives. HCT gets the patient out of ‘fight/flight’, resetting the pain loop, balancing the autonomic nervous system, reducing/controlling stress and anxiety, increasing restorative sleep, and helping with PTSD. Their 5-day protocol is not only changing patients’ lives but is also dramatically decreasing the overall burden on the U.S. healthcare system.

Catasys’ OnTrak Program

Rick Anderson, President & COO

Through predictive analytics, Catasys identifies, engages, and treats behavioral care avoidant people who are suffering from untreated behavioral health conditions that are exacerbating chronic medical disease. By applying advanced tools and proprietary insights, during its 52-week program. Catasys care coaches motivate behavior change, resulting in better health, improved resiliency, and reduced costs: total claims paid, a reduction in ED and inpatient utilization, as well as a reduction in professional costs, such as doctor fees. OnTrak’s retention is 80%: 4 times the average behavioral health treatment retention.

Healthpiper, LLC

Joshua Freedman, MD, Founder & CEO

Among the millions of Americans identified as depressed by their primary care doctor, almost two-thirds don’t get treatment. As a psychiatrist, Dr. Freedman recognized the challenges his patients faced, particularly those suffering from anxiety and depression, to travel across town to meet with their doctor. healthPiper: a mobile medication-based treatment program for patients with depression and anxiety that uses a cost-effective “concierge style” that harnesses mobile technology, coupling it with innovative approaches for delivering meds and staying patient-connected, all at less than half the typical cost of care.

ImpediMed’s SOZO® Digital Health Platform

Richard Carreon, Managing Director & CEO

The post-surgical complication of lymphedema (in which fluid builds up in the extremities due to damage of the lymph system) is so significant that it is taken for granted. SOZO® provides a critical tool for the early detection, monitoring and management of conditions like lymphedema. When used immediately upon cancer diagnosis, SOZO enables the monitoring of subtle changes in breast cancer patients – detecting lymphedema as much as 4-10 months earlier than other methods, allowing for early intervention and prevention of disease progression, decreasing the development of persistent, possibly irreversible, lymphedema in breast cancer patients by as much as 95%.

MedCline by Amenity Health, Inc.

Aaron Clark, CEO

Gastroesophageal reflux disease (GERD) affects 20% of the adult US population. For under $300, the MedCline Reflux Relief System is more effective than medications at reducing nighttime GERD symptoms, more effective than surgery at reducing Silent Reflux symptoms, and it provides physicians and patients with a powerful and effective alternative to Proton Pump Inhibitor medications and surgery. It has been clinically studied with patients with typical reflux symptoms – as well as, laryngopharyngeal reflux, pregnancy reflux, post-esophagectomy, and lung transplant patients with reflux – with consistent positive results.